Search details
1.
The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel treatment strategies in operable renal cell cancer - a study protocol.
BMC Cancer
; 21(1): 1238, 2021 Nov 18.
Article
in English
| MEDLINE | ID: mdl-34794412
2.
Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study.
Lancet Oncol
; 15(6): 620-30, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24745696
3.
Refining the Intraoperative Identification of Suspected High-Grade Glioma Using a Surgical Fluorescence Biomarker: GALA BIDD Study Report.
J Pers Med
; 13(3)2023 Mar 13.
Article
in English
| MEDLINE | ID: mdl-36983696
4.
ctDNA monitoring using patient-specific sequencing and integration of variant reads.
Sci Transl Med
; 12(548)2020 06 17.
Article
in English
| MEDLINE | ID: mdl-32554709
Results
1 -
4
de 4
1
Next >
>>